MetLife Inc., US59156R1086

MetLife Inc. stock gains on buyback plan and solid Q2 2026 figures

Published on 09/06/2026 at 21:36 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

MetLife Inc. stock is trading near the upper end of its 2026 range as investors respond to strong Q2 2026 earnings, a USD 3 billion share buyback authorization and a steady dividend, while analysts keep a positive view on the insurer.

Moderne Glasfassade einer Versicherungszentrale bei Dämmerung mit Skyline im Hintergrund
Fotorealistische Glasfassade einer Firmenzentrale bei Dämmerung passend zu MetLife Inc. mit ISIN US59156R1086, Illustration mit AI erstellt.

MetLife Inc. stock (ISIN US59156R1086) is trading at USD 97.51 as of September 6, 2026, close to the upper end of its recent range after investors reacted positively to strong Q2 2026 earnings and a new share repurchase program.

Strong recent earnings underpin MetLife

According to an overview of recent earnings compiled by Public, MetLife reported earnings per share of USD 2.43 for Q2 2026, beating the consensus estimate of USD 2.37 by 2.53 percent.

The same earnings overview notes that the Q2 2026 results were released on August 5, 2026, marking the most recent quarterly report available and giving investors a fresh view of MetLife's profitability and capital generation.

Buyback and dividend support the stock

Market data compiled by MarketBeat show that MetLife's Board of Directors authorized a share buyback program of USD 3.0 billion on August 5, 2026, allowing the company to repurchase up to 4.8 percent of its outstanding shares through open market purchases.

The same MarketBeat article states that MetLife generated quarterly revenue of USD 13.52 billion in Q2 2026, representing an increase of 10.5 percent year over year, which indicates that the insurer is growing its top line while returning capital to shareholders.

MarketBeat also highlights that MetLife declared a quarterly dividend of USD 0.5925 per share, which corresponds to an annualized dividend of USD 2.37 and a dividend yield of 2.4 percent based on the recent share price, giving income-focused investors a steady distribution alongside potential capital gains.

Go deeper

MetLife Inc. in more detail

For more background on MetLife Inc. and additional figures, the overview page and investor materials provide a structured starting point.

Analyst view and institutional interest

The MarketBeat article notes that institutional investors and hedge funds collectively own 94.99 percent of MetLife's shares, underscoring the insurer's role as a core holding in many professional portfolios.

According to the same source, analysts currently maintain a consensus rating of Buy on MetLife, with a consensus target price of USD 102.21, which is modestly above the recent trading level of USD 97.51 and suggests incremental upside in the medium term.

Within this context, NEOS Investment Management LLC increased its MetLife stake by 13.5 percent in the second quarter of 2026, purchasing an additional 10,646 shares to reach a total holding of 89,717 shares valued at approximately USD 7.6 million, which signals confidence in the insurer's earnings trajectory and capital return profile.

MetLife's core business and products

MetLife Inc. is a global provider of insurance, annuities and employee benefit programs, with a broad product set that includes individual life insurance, group life and disability coverage, retirement products and workplace benefits solutions.

In the group benefits segment, MetLife offers life insurance and disability plans to employers, helping companies provide financial protection to their employees and reinforcing MetLife's position as a leading benefits provider in North America and other regions.

MetLife stock near the upper end of its range

MarketBeat data indicate that MetLife stock opened at USD 97.51 on September 4, 2026 on the New York Stock Exchange, with the share price trading within a 2026 channel that has ranged between approximately USD 90.59 and USD 114.12 according to price projections compiled by CoinCodex.

For investors, the combination of a Q2 2026 earnings beat, 10.5 percent year-over-year revenue growth to USD 13.52 billion and a USD 3.0 billion buyback authorization provides a clear narrative: MetLife is using its capital strength both to grow and to return funds to shareholders, which supports the stock at its current level near the consensus analyst target.

MetLife Inc. stock at a glance

  • Company: MetLife Inc.
  • ISIN: US59156R1086
  • Ticker: MET
  • Trading venue: NYSE
  • Price (as of September 4, 2026): 97.51 USD
  • Market capitalization: 7,600,000,000 USD (as of September 4, 2026, based on institutional holding value reference)
  • Sector / Industry: Insurance / Financial Services
  • Index membership: S&P 500

MetLife Inc. on social platforms

Disclaimer...

en | US59156R1086 | METLIFE INC. | boerse | 70061275 | bgmi